Topic: Disability Visual Aids
Author: AmblyoPlay
Published: 2024/10/15
Publication Type: Product Release, Update
Contents: Summary – Introduction – Main Item – Related Topics
Synopsis: AmblyoPlay launches Active Peripheral Stimulation (APS) intended to advance treatment of peripheral vision deficiencies and improve effectiveness of home-based vision therapy. APS technology, available within the existing AmblyoPlay Vision Therapy, is tailored to improve peripheral vision by actively engaging and stimulating the peripheral areas of the retina. People with amblyopia and other binocular vision problems often struggle with depth perception, hand-eye coordination, and reading difficulties and may experience frustration or lower self-esteem due to challenges in everyday tasks like driving, sports, and learning.
Why it matters: AmblyoPlay’s introduction of Active Peripheral Stimulation (APS) technology represents a significant advancement in the field of vision therapy, particularly for treating peripheral vision deficiencies. This innovation is noteworthy for several reasons. Firstly, it addresses a widespread issue, as amblyopia affects up to 5% of the global population. Secondly, APS technology actively engages and stimulates peripheral areas of the retina, potentially improving spatial awareness and overall visual function. The integration of APS into AmblyoPlay’s existing gamified vision therapy platform enhances the effectiveness of home-based treatments while maintaining user engagement. This approach not only targets visual impairments like amblyopia, strabismus, and convergence insufficiency but also addresses associated challenges such as depth perception and hand-eye coordination. By making vision therapy more accessible, engaging, and effective, AmblyoPlay’s APS technology could significantly impact the quality of life for individuals with visual impairments, potentially improving outcomes in daily activities, education, and overall well-being – Disabled World.
Introduction
AmblyoPlay, a leading innovator in vision therapy solutions, proudly announces the launch of its revolutionary technology: Active Peripheral Stimulation (APS). APS, which is intended to advance the treatment of peripheral vision deficiencies, is a significant step towards improving the effectiveness of home-based vision therapy.
Main Item
APS technology, available within the existing AmblyoPlay Vision Therapy, is tailored to improve peripheral vision by actively engaging and stimulating the peripheral areas of the retina. This unique approach improves the brain’s ability to integrate peripheral inputs, resulting in increased spatial awareness.
While amblyopia (often referred to as “lazy eye”) may sound like a very niche problem, up to 5% of the population suffer from this vision disorder worldwide. Nonetheless, it remains a substantial global vision problem, and public health initiatives of early screening, treatment, and management are critical.
Continued…
People with amblyopia and other binocular vision problems often struggle with depth perception, hand-eye coordination, and reading difficulties and may experience frustration or lower self-esteem due to challenges in everyday tasks like driving, sports, and learning.
AmblyoPlay raises the bar for treating amblyopia, strabismus, convergence insufficiency, and other visual impairments by incorporating APS technology within vision therapy. The technology has been seamlessly incorporated into therapeutic exercises, ensuring a smooth and engaging experience for users of all ages.
“With APS, we’re expanding the boundaries of what vision therapy can achieve,” said Matic Vogrič, CEO of AmblyoPlay.
AmblyoPlay Vision Therapy
AmblyoPlay was born from conversations with doctors and parents, all facing a common challenge: how to keep young patients motivated during vision therapy homework. Existing solutions were repetitive and disengaging, leading to frustration. Therefore, AmblyoPlay transformed vision therapy into a gamified experience-turning a routine task into something fun.
Continued…
This playful approach not only keeps patients engaged but also improves adherence to therapy, helping families and doctors work together toward better vision outcomes.
AmblyoPlay is a vision therapy solution designed to treat vision impairments such as amblyopia (lazy eye), strabismus (crossed eyes), convergence insufficiency, double vision, and other binocular vision disorders. It complements in-office vision therapy and increases at-home vision therapy adherence through gamification.
By offering personalized and evidence-based therapy, AmblyoPlay provides effective solutions for children and adults alike, bringing engaging therapy into the comfort of users’ homes.
Until now, it has helped more than 25.000 users worldwide. Discover more about AmblyoPlay at amblyoplay.com
Related Information
Attribution/Source(s):
This quality-reviewed publication was selected for publishing by the editors of Disabled World due to its significant relevance to the disability community. Originally authored by AmblyoPlay, and published on 2024/10/15, the content may have been edited for style, clarity, or brevity. For further details or clarifications, AmblyoPlay can be contacted at amblyoplay.com. NOTE: Disabled World does not provide any warranties or endorsements related to this article.
Page Information, Citing and Disclaimer
Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.
Cite This Page (APA): AmblyoPlay. (2024, October 15). Revolutionary Vision Therapy: AmblyoPlay Unveils Peripheral Sight Enhancer. Disabled World. Retrieved October 15, 2024 from www.disabled-world.com/assistivedevices/visual/amblyoplay.php
Permalink: <a href=”https://www.disabled-world.com/assistivedevices/visual/amblyoplay.php”>Revolutionary Vision Therapy: AmblyoPlay Unveils Peripheral Sight Enhancer</a>: AmblyoPlay launches Active Peripheral Stimulation (APS) intended to advance treatment of peripheral vision deficiencies and improve effectiveness of home-based vision therapy.
Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.
